CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 53 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2006-11-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,500 | 234,419 | ||
| 2006-11-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 65,581 |
| 2006-11-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,500 | 234,419 | ||
| 2006-11-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 65,581 |
| 2006-11-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,500 | 224,419 | ||
| 2006-10-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 62,081 |
| 2006-10-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,500 | 237,919 | ||
| 2006-09-28 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 58,581 |
| 2006-09-28 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,500 | 241,419 | ||
| 2006-08-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 55,081 |
| 2006-08-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,500 | 244,919 | ||
| 2006-08-11 | ADAMS DONALD E 10% owner | Sale | −15,000 | $1.13 | $17K | 5,019,977 |
| 2006-08-11 | ADAMS DONALD E 10% owner | Sale | −15,000 | $1.13 | $17K | 5,019,977 |
| 2006-08-01 | DEES H CRAIG Chief Executive Officer | Exercise or conversion | +3,125 | $0.32 | $1K | 1,413,484 |
| 2006-08-01 | DEES H CRAIG Chief Executive Officer | Exercise or conversion · Stock Options (Right to Buy) | −3,125 | 59,375 | ||
| 2006-07-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 51,581 |
| 2006-07-30 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,500 | 248,419 | ||
| 2006-07-05 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion | +3,500 | $1.10 | $4K | 48,081 |
| 2006-07-05 | CULPEPPER PETER R Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) | −3,500 | 251,919 | ||
| 2006-06-23 | FUCHS STUART Director | Grant or award · Stock Option (right to buy) | +50,000 | 50,000 |
Page 27 of 28 · 553 trades